MedPath

Subdermal implantation of the collagen-elastin-matrix Matriderm® to improve profile and skin structure of degenerative changes in the midface region [Subkutaner einsatz der kollagen-elastin-matrix Matriderm® zur verbesserung von profil und hautstruktur bei degenerativen veränderungen des mittelgesichtes]

Completed
Conditions
Skin quality in the mid-face
Degenerative structure of profile and/or skin quality in the mid-face, caused by disease or ageing
Skin and Connective Tissue Diseases
Registration Number
ISRCTN35051281
Lead Sponsor
Dr Suwelack Skin and Health Care AG (Germany)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

Healthy adults aged 40 - 65 years, either sex

Exclusion Criteria

1. Severe allergies
2. Severe acute or chronic diseases
3. Skin infections

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath